Institut de Pathologie et de Génétique ASBL
329.1 FTEInstitut de Pathologie et de Génétique reported revenue of €53.2m for the 2025 financial year (annual accounts filed with the NBB on 19 Jun 2026), with 329.1 full-time equivalents.
By total assets for 2025, Institut de Pathologie et de Génétique ranks among the 10 largest of the 500 companies in its sector (NACE 8691) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Institut de Pathologie et de Génétique shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +33 % Equity +11 % Total assets +12 % Headcount (avg FTE) +9 %
Accounts of the company itself (not consolidated).
The full file covers 19 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Institut de Pathologie et de Génétique's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €53.2m | ||||
| Net result | 710,396 € | ||||
| Equity | €37.6m | ||||
| Cash | €3.41m | ||||
| EBITDA | €4.18m | ||||
| Total assets | €48.2m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 19 Jun 2026
- Year ended 31 Dec 2024filed on 03 Jul 2025
- Year ended 31 Dec 2023filed on 08 Jul 2024
- Year ended 31 Dec 2022filed on 27 Jun 2023
- Year ended 31 Dec 2021filed on 22 Jun 2022
Institut de Pathologie et de Génétique's financial analysis
- Solvency78.1%sector median: 66.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Institut de Pathologie et de Génétique
18 active director(s) in the register.
and 12 more
Institut de Pathologie et de Génétique's shareholders and holdings →Institut de Pathologie et de Génétique's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0408.333.871
- VAT number
- BE0408333871
- Peppol
- Registered · 0208:0408333871 · as of 10 Nov 2026
- Legal form
- ASBL
- Incorporated
- 24 Apr 1971
- Registered office
- 6041 Charleroi
- Size
- Large · 329.1 FTE
- Latest accounts
- 2025 · filed on 19 Jun 2026
- Activity
- Diagnostic imaging services and medical laboratory activities (NACE 86910)
Institut de Pathologie et de Génétique (ASBL) has been based in Charleroi since 1971, active in: diagnostic imaging services and medical laboratory activities. For 2025, it reports revenue of €53.2m, a net profit of 710,396 € and equity of €37.6m. With 329.1 full-time equivalents, it is a large enterprise by headcount. Its solvency stands at 78.1%, above the median of its sector (66.2%).
Guide: Checking a Belgian supplier invoice: numbers and IBAN →
Companies similar to Institut de Pathologie et de Génétique
Companies in the same business, of comparable size and area, outside its group.
- Le Centre Universitaire inter Régional d' Expertise en anatomie Pathologique Hospitalière Hospital activities Charleroi · balance sheet €13.0m
- SYNLAB Belgium Diagnostic imaging services and medical laboratory activities Fleurus · balance sheet €135.2m
- Radiology Partners Europe Activities of holding companies Ghent · balance sheet €68.9m
- De ARK Activities of head offices Wortegem-Petegem · balance sheet €9.86m
- Technologue Imagerie Medicale Services Diagnostic imaging services and medical laboratory activities Villers-la-Ville · balance sheet 460,120 €
- Laboratoire hospitalier universitaire de Bruxelles - Universitair Laboratorium Brussel Diagnostic imaging services and medical laboratory activities Brussels · balance sheet €27.2m
- Centrum voor Medische Analyse Diagnostic imaging services and medical laboratory activities Herentals · balance sheet €44.4m
- Medisch Centrum voor Huisartsen Diagnostic imaging services and medical laboratory activities Leuven · balance sheet €23.8m
Frequently asked questions about Institut de Pathologie et de Génétique
What is the revenue of Institut de Pathologie et de Génétique?
According to the 2025 annual accounts filed with the NBB, the revenue of Institut de Pathologie et de Génétique amounts to 53,232,206 €.
What is the VAT number of Institut de Pathologie et de Génétique?
In Belgium, the VAT number is the company number prefixed with BE: BE0408333871 for Institut de Pathologie et de Génétique, if the company is VAT-registered. Its company number (CBE) is 0408.333.871.
Where is the registered office of Institut de Pathologie et de Génétique?
According to the CBE register, the registered office of Institut de Pathologie et de Génétique is in 6041 Charleroi.
What is the equity of Institut de Pathologie et de Génétique?
At the close of the 2025 financial year, the equity of Institut de Pathologie et de Génétique amounts to 37,607,879 €, a solvency of 78.1% of total assets.
How many people work at Institut de Pathologie et de Génétique?
329.1 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Institut de Pathologie et de Génétique?
The register lists 18 active mandates at Institut de Pathologie et de Génétique. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Institut de Pathologie et de Génétique within its sector?
By total assets for 2025, Institut de Pathologie et de Génétique ranks among the 10 largest of the 500 companies in its sector (NACE 8691) in Belgium that filed accounts for that financial year.
The full file of Institut de Pathologie et de Génétique
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →